Eli Lilly & Co. (LLY) has announced the introduction of digital health services for patients in the United States who are dealing with obesity, migraine, and diabetes. This groundbreaking initiative, known as LillyDirect, offers access to independent healthcare providers and the convenience of home delivery for certain Lilly drugs through third-party dispensing services.
Convenient Online Pharmacy
LillyDirect features an online pharmacy that provides numerous benefits to patients. It automatically applies savings card discounts for eligible individuals, ensuring cost effectiveness. Additionally, all medicines will be shipped free of charge.
Enhanced Telehealth Experience
In addition to the online pharmacy, LillyDirect connects patients with independent telehealth providers. These healthcare professionals can either complement a patient’s existing primary care or serve as a viable alternative to in-person visits for specific conditions.
Future Innovations
LillyDirect is an evolving program with plans to introduce additional services in the future. These upcoming features aim to assist patients in adhering to their prescribed medications effectively.
Addressing Concerns
While Lilly’s new obesity drug, Zepbound, received regulatory approval in the United States in November, concerns remain about long-term patient compliance. Some individuals may struggle due to possible side effects, such as nausea and vomiting. Despite this, Lilly shares have surged by 1.2% in pre-market trading on Thursday and have experienced remarkable growth of over 70% in the past 12 months. This impressive performance stands in contrast to the S&P 500, which has gained 22% during the same period.
